Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer
JNCI Cancer Spectrum · 31.08.2023 · 7 (5)
DOI: 10.1093/jncics/pkad067 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 14.09.2023. Verfasst von Xu Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Medicaid, Breast Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute of the National Institutes of Health.
Abstract (Originalsprache)
Female breast cancer is a common cancer in young adults, an age group with the highest uninsured rate. Among 51 675 young adult women (ages 18-39 years) diagnosed with breast cancer between 2011 and 2018 in the National Cancer Database, we estimated changes in guideline-concordant treatment receipt, treatment timeliness, and survival associated with the Affordable Care Act Medicaid expansion. Of young adults with stage I-III estrogen receptor–positive or progesterone receptor–positive breast cancer, Medicaid expansion was associated with a net increase of 2.42 percentage points (95% confidence interval [CI] = 0.56 to 4.28 percentage points) in the percentage receiving endocrine therapy. Among all young adults with stage I-III breast cancer, Medicaid expansion was associated with a net reduction of 1.65 percentage points (95% CI = 0.08 to 3.22 percentage points) in treatment delays defined as treatment initiation of at least 60 days after diagnosis and a net increase of 1.00 percentage points (95% CI = 0.21 to 1.79 percentage points) in 2-year overall survival. Our study provides evidence of benefit in cancer care and outcomes from Medicaid expansion among the young adult population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
- Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
- Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA, USA.
- Department of Oncology, Mayo Clinic, Rochester, MN, USA.
- Department of Epidemiology, Emory Rollins School of Public Health, Atlanta, GA, USA.
ORCID-Profile: Xu Ji, Jingxuan Zhao, Ann C Mertens, Xuesong Han
Förderung
- NCI NIH HHS
- National Cancer Institute of the National Institutes of Health
Zitieren
APA
Ji, X., Shi, K. S., Ruddy, K. J., Zhao, J., Mertens, A. C., Yabroff, K. R., Castellino, S. M., & Han, X. (2023). Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer. JNCI Cancer Spectrum, 7(5). https://doi.org/10.1093/jncics/pkad067
Vancouver
Ji X, Shi KS, Ruddy KJ, Zhao J, Mertens AC, Yabroff KR, et al. Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer. JNCI Cancer Spectrum. 2023;7(5). doi:10.1093/jncics/pkad067
BibTeX
@article{Ji2023,
author = {Ji, Xu and Shi, Kewei Sylvia and Ruddy, Kathryn J and Zhao, Jingxuan and Mertens, Ann C and Yabroff, K Robin and Castellino, Sharon M and Han, Xuesong},
title = {Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer},
journal = {JNCI Cancer Spectrum},
year = {2023},
volume = {7},
number = {5},
doi = {10.1093/jncics/pkad067}
}
EUVIMED